banner
Pwodwi kategori
Kontakte nou

Kontakte:Errol Zhou (Mesye.)

Tel: plis 86-551-65523315

Mobile/WhatsApp: plis 86 17705606359

QQ:196299583

Skype:lucytoday@hotmail.com

Imèl:sales@homesunshinepharma.com

Ajoute:1002, Huanmao Bilding, No.105, Mengcheng Wout, Hefei Vil, 230061, Lachin

APIs ak entèmedyè
Etil 2- (3-Formyl-4-Isobutoxyphenyl) -4-Methylthiazole-5-Carboxylate CAS 161798-03-4

Etil 2- (3-Formyl-4-Isobutoxyphenyl) -4-Methylthiazole-5-Carboxylate CAS 161798-03-4

NON CAS: 161798-03-4
Molekilè fòmil: C18H21NO4S
Molekilè Pwa: 347.429
EINECS NON: 700-743-7
MDL NON: N / A

Pwodwi detay

Deskripsyon Product:

Non pwodwi: etil 2- (3-Formyl-4-Isobutoxyphenyl) -4-Methylthiazole-5-Carboxylate CAS pa: 161798-03-4

Sinonim:

etil 2- [3-formyl-4- (2-methylpropoxy) fenil] -4-methyl-1,3-tiazol-5-carboxylate;

Chimik& Pwopriyete fizik:

Aparans: blan poud

Tès: ≥99.0%

Dansite: 1.2g / cm3

Pwen bouyi: 495,9 ℃ nan 760 mmHg

Flash Point: 253.7

Febuxostat entèmedyè;

Febuxostat se yon nouvo jenerasyon inhibiteurs xanthine oxidase devlope pa konpayi anperè nan Japon. Yo itilize li pou trete iperuricemiya (gout) klinikman. Estrikti li se konplètman diferan de sa yo ki an Xanthine oxidase inibitè devlope 40 ane de sa. Li se yon nouvo ak trè efikas ki pa purin xantin oksidaz selektif inibitè. Xanthine oxidase se yon anzim kle pou ankouraje pwodiksyon asid asid.

An fevriye 2009, Administrasyon Etazini pou Manje ak Medikaman (FDA) te apwouve febuxostat pou tretman alontèm sou pasyan yo genyen nan hyperuricemi gout.


Si ou enterese nan pwodwi nou yo oswa ou gen nenpòt kesyon, tanpri, ezite kontakte nou!

Pwodwi anba patant yo ofri pou R& D objektif sèlman. Sepandan, responsablite final la bay manti sèlman ak achtè a.


Baj popilè: etil 2- (3-formyl-4-isobutoxyphenyl) -4-methylthiazole-5-carboxylate cas 161798-03-4, manifaktirè, founisè, faktori, achte, nan stock

Voye rechèch